Quantcast
Channel: Apprentice Millionaire Portfolio » Oncolytics
Browsing all 4 articles
Browse latest View live

Image may be NSFW.
Clik here to view.

Oncolytics Biotech Inc. Update Target $9.00

clinical trial capsules (Photo credit: Esthr) Sept.13 Oncolytics Biotech Inc. ONCY  NYSE Investment recommendation Oncolytics provided an update on its Phase III clinical development of Reolysin in...

View Article



Image may be NSFW.
Clik here to view.

Oncolytics Biotech Inc. Q4 AND FULL YEAR 2012 RESULTS

Image via CrunchBase ONC : TSX : C$3.12 ONCY : NASDAQ BUY  Target: C$8.00 COMPANY DESCRIPTION: Oncolytics Biotech is a biotechnology company with a biologic therapy in late stage development for the...

View Article

Image may be NSFW.
Clik here to view.

Oncolytics Biotech Inc. Risk/Reward

ONC: TSX : C$2.55 ONCY : NASDAQ BUY  Target: C$8.00 COMPANY DESCRIPTION: Oncolytics Biotech is a biotechnology company with a biologic therapy in late stage development for the treatment of various...

View Article

Image may be NSFW.
Clik here to view.

Oncolytics Biotech Inc. MORE QUESTIONS THAN ANSWERS

ONC : TSX : C$2.00 ONCY : NASDAQ BUY  Target: C$6.50 COMPANY DESCRIPTION: Oncolytics Biotech is a biotechnology company with a biologic therapy in late-stage development for the treatment of various...

View Article
Browsing all 4 articles
Browse latest View live




Latest Images